Clinical research points to autism as a condition involving impaired neurological function, immune dysregulation, and unbalanced intestinal flora. MSC therapy is studied for its potential to support all three systems simultaneously, published across peer-reviewed neurology and immunology journals.
Autism spectrum disorders (ASD) affect social learning, communication, and language, often alongside sensory hypersensitivity and repetitive behaviour. Many patients also experience chronic digestive issues that conventional medicine treats separately.
Increasing international research links ASD to three overlapping systems, impaired neurological function, defective immune response, and unbalanced intestinal flora. Conventional therapies address only behaviour through adapted learning or diet.
Difficulty with social interaction, verbal and non-verbal communication, and reciprocal conversation. The hallmark ASD presentation that leads to most diagnoses, and the area where improvements matter most to families.
Sensory hypersensitivity to sound, light, touch, and textures, often paired with repetitive behaviours, restricted interests, and difficulty with routine changes. Can significantly affect daily family life.
Underlying differences in brain connectivity and neurological development. MSC therapy is studied for its potential to support neuronal function and reduce neuroinflammation that may contribute to cognitive and behavioural symptoms.
A significant subset of ASD patients show markers of chronic immune activation and inflammation. MSC therapy works directly in this pathway, modulating inappropriate immune activity and calming systemic inflammation.
Chronic constipation, diarrhoea, and food sensitivities are common but often under-addressed in autism care. MSC therapy has documented effects on intestinal inflammation and gut barrier function that may support this overlooked dimension.
The same highly potent umbilical-cord mesenchymal stem cells used across all our condition protocols, delivered in a child-appropriate dosing and schedule tailored to the patient's age, weight, and symptom profile.
Protocol is designed around the three-system model, neurological support, immune recalibration, and intestinal inflammation. MSCs exert effects on all three through their well-documented immunomodulatory and anti-inflammatory properties.
Cell therapy is combined with specialised paediatric-focused support. Families receive practical guidance on nutrition, behavioural context, and expectations throughout the treatment course.
The following improvements have been reported by past patients. Results vary by individual, improvements cannot be guaranteed.
Conventional autism therapies focus only on behaviour. Cell therapy addresses the biology underneath, the inflammation, the immune dysregulation, the neurological differences that drive the symptoms. Share your child's diagnosis, developmental history, and any recent bloodwork. Our medical team will review the case personally.
Request a Case Review